MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Haemonetics Company Profile (NYSE:HAE)

Consensus Ratings for Haemonetics (NYSE:HAE) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $40.00 (23.15% upside)

Analysts' Ratings History for Haemonetics (NYSE:HAE)
Show:
DateFirmActionRatingPrice TargetActions
2/2/2016Jefferies GroupBoost Price TargetBuy$38.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Barrington ResearchBoost Price TargetOutperform$38.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016William BlairReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/1/2016BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/14/2015BTIG ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/23/2015Raymond JamesDowngradeMarket Perform -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Benchmark Co.Lower Price TargetHold$42.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Jefferies GroupLower Price TargetBuy$47.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Barrington ResearchLower Price TargetOutperform$43.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015Jefferies GroupLower Price TargetBuy$48.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015Barrington ResearchUpgradeMarket Perform -> Outperform$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015Benchmark Co.Boost Price TargetHold$39.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015Barrington ResearchDowngradeOutperform -> Market Perform$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015Jefferies GroupBoost Price TargetBuy -> Buy$45.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Morgan StanleySet Price TargetHold$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Jefferies GroupBoost Price TargetBuy$41.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Barrington ResearchInitiated CoverageOutperform$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Jefferies GroupBoost Price TargetBuy$38.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/21/2014Jefferies GroupReiterated RatingBuy$36.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014Jefferies GroupLower Price TargetBuy$38.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2014Benchmark Co.Lower Price Target$46.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2014Jefferies GroupLower Price Target$45.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014William BlairDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2014SidotiUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/9/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha